Vega Investment Solutions Acquires New Shares in Regeneron Pharmaceuticals, Inc. $REGNMarket Beat·1 hour agoREGN-0.66%
$100 Invested In Regeneron Pharmaceuticals 15 Years Ago Would Be Worth This Much Todaybenzinga_article·11 hours agoREGN-0.66%
12:38 ETRegeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit - Hagens Berman Sobol Shapiro LLPprnewswire·18 hours agoREGN-0.66%
Does First-in-Class FOP Drug Approval Transform the Bull Case For Regeneron Pharmaceuticals (REGN)?Simplywall·1 day ago, 06:45 AMREGN-0.66%
Weekly Recap | Regeneron Pharma +3.8%, FDA clears rare-disease drugWeekly Review·Aug 22 at 12:35 AMREGN-0.66%
Intellia Therapeutics Earnings Call Highlights Clinical MomentumTip Ranks·Aug 21 at 07:20 PMNTLA-2.18%REGN-0.66%
Regeneron Stock (REGN) Buckling as Shareholders Sue Over Cancer Drug ClaimsTip Ranks·Aug 21 at 06:58 AMREGN-0.66%
04:39 ETRegeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - REGNprnewswire·Aug 21 at 03:40 AMREGN-0.66%
Diversify Advisory Services LLC Buys New Holdings in Regeneron Pharmaceuticals, Inc. $REGNMarket Beat·Aug 21 at 03:08 AMREGN-0.66%
Regeneron Secures FDA Approval For Ultra-Rare Bone Disorder Drugbenzinga_article·Aug 20 at 08:25 AMREGN-0.66%
Regeneron’s Pasatru wins FDA approval in ultra-rare ‘stone man disease’Pharmaceutical Technology·Aug 20 at 05:39 AMREGN-0.66%
22:26 ETREGN Stockholders Interested in Leading the Class Action Against Regeneron Pharmaceuticals, Inc. Should Contact Robbins LLP for Information About Recovering Their Lossesprnewswire·Aug 19 at 09:26 PMREGN-0.66%
